← Leaderboards
Todd Levine
Cnd Life Sciences, Inc.
$7,820,585
Attributed
$7,820,585
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.3M · FY2020–24$2.5M$1.9M$1.3M$625K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,820,585 · 3
By mechanism
R44$7,820,585 · 3
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Pathologic”
- Ted Ross · University Of Georgia$68,763,143
- Dale Sandler · Social And Scientific Systems, Inc.$59,740,435
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Leonard Freedman · Leidos Biomedical Research, Inc.$41,527,040
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
Research focus
PathologicAffectDiagnostic TestsDiagnosticCutaneousDetectionNeurodegenerative DisordersSurrogate EndpointSensitivity And SpecificityPeripheral Nervous SystemSynucleinopathySymptomsAlpha SynucleinDepositionDiagnosisBiopsyNerve FibersLaboratoriesDementia With Lewy BodiesClinical TrialsAccurate DiagnosticsAlzheimer&AposEffective TherapyFeasibility Studies
Grant awards (7)
Cutaneous Phosphorylated Alpha-Synuclein for Detection of Prodromal Synucleinopathies$954,862
R44 · FY2024 · NS · contact PI
A Diagnostic Test for Dementia with Lewy Bodies$1,168,467
R44 · FY2023 · AG · contact PI
Cutaneous Phosphorylated Alpha-Synuclein for Detection of Prodromal Synucleinopathies$952,525
R44 · FY2023 · NS · contact PI
A Diagnostic Test for Dementia with Lewy Bodies$1,239,804
R44 · FY2022 · AG · contact PI
Cutaneous Phosphorylated Alpha-Synuclein for Detection of Prodromal Synucleinopathies$1,092,613
R44 · FY2022 · NS · contact PI
PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for SmallBusiness Innovation Research Grant Applications (Parent SBIR [R43/R44] ClinicalTrial Not Allowed$1,198,087
R44 · FY2021 · NS · contact PI
PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for SmallBusiness Innovation Research Grant Applications (Parent SBIR [R43/R44] ClinicalTrial Not Allowed$1,214,227
R44 · FY2020 · NS · contact PI